MTOR and cancer: To further evaluate and promote the translation of our findings into the clinic, we developed a highly multiplexed targeted MS assay for absolute quantitation of 90 signature peptides, associated with cancer metabolism, central energy metabolism, RNA regulation, and members of the PI3K/AKT/mTOR, EIF2, and EGFR/RAS/RAF signaling pathways.